GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CRISPR Therapeutics CRSP · USD

Health Care · US listing · 🇺🇸 United States

Compare

50.04

-0.06%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

CRISPR Therapeutics and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
CRISPR Therapeutics CRSP 50.04$4.77bn—-16569.8%— -0.06%
Lantheus Holdings LNTH 101.01$6.91bn29.615.2%— +0.40%
Avantor AVTR 15.91$10.85bn—-8.1%— +2.84%
Grifols SA ADR GRFS 8.69$5.91bn10.25.3%1.10% +3.08%
Celcuity CELC 70.37$2.78bn—-114962.3%— +5.36%
Immunovant IMVT 35.15$7.15bn——— +15.13%
Mirum Pharmaceuticals MIRM 93.18$4.82bn—-4.5%— -0.58%
RadNet RDNT 78.38$5.86bn352.0-0.9%— +3.13%
Alkermes Plc ALKS 46.17$7.81bn20.923.6%— +0.59%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.